Livers of transgenic mice that constitutively overexpress human TGF-α from the mouse metallothionein 1 promoter frequently developed multifocal, well-differentiated HCCs [147,148,153] and treatment of these mice with hepatic carcinogens further accelerated HCC development [153]. The gene discussed is TGFA; the disease is hepatocellular carcinoma.